Cyclosporin A Suppresses Insulin Autoantibodies and Heterologous Insulin Antibodies in Type I Diabetic Children
1988; American Diabetes Association; Volume: 37; Issue: 8 Linguagem: Inglês
10.2337/diab.37.8.1049
ISSN1939-327X
AutoresLuís Castaño, Christian Boîtard, Pierre-François Bougnères,
Tópico(s)Diabetes Treatment and Management
ResumoWe report that cyclosporin A (CsA) suppresses the insulin autoantibodies that are present before insulin therapy in the sera of one-third of studied type I (insulin-dependent) diabetic children. CsA also reversibly blocks the production of antibodies after exogenous insulin injection, whereas high titers of heterologous insulin antibody are observed in all type I patients not receiving CsA.
Referência(s)